Healthcare Nov 02, 2021 05:24 PM (GMT+8) · EqualOcean
Recently, Shanghai Ouyi Biomedical Technology Co., Ltd. announced the completion of a + round of financing of nearly 100 million yuan. A + round of financing was led by Sinopharm capital, followed by the old shareholder Dongzheng capital again, and Dingshi Huize capital joined the follow-up investment. Founded in 2009, Ouyi biology is a high-tech enterprise committed to multi omics detection services and molecular diagnosis product development. This round of financing will be mainly used to accelerate the R & D of molecular diagnostic products, accelerate the registration and application process of R & D pipeline products, improve the joint analysis ability of multi omics and the R & D innovation and database construction level of spatial multi omics technology.